Not applicableUnknownNCT04555109What this trial is testingConvalescent Plasma for COVID-19 Research Donor StudyWho this might be right forCovid19 The Hospital for Sick Children 1,000
Not applicableStudy completedNCT02990351What this trial is testingEfficacy of Loco-regional Treatment for Hepatocellular Carcinoma Prior to Living Donor Liver Transplantation in EgyptWho this might be right forHepatocellular Carcinoma (HCC)Living Donor Liver Transplantation Ain Shams University 29
Testing effectiveness (Phase 2)Looking for participantsNCT03266653What this trial is testingEBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV InfectionWho this might be right forEpstein-Barr Virus InfectionsPrimary Immune Deficiency Disorder New York Medical College 20
Early research (Phase 1)Temporarily pausedNCT03494569What this trial is testingTotal Marrow and Lymphoid Irradiation, Fludarabine, and Melphalan Before Donor Stem Cell Transplant in Treating Participants With High-Risk Acute Leukemia or Myelodysplastic SyndromeWho this might be right forAcute Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia+5 more City of Hope Medical Center 36
Not applicableStudy completedNCT04088695What this trial is testingEffect of a Web Page Based on a Motivational Video for Voluntary Blood DonationWho this might be right forBlood Donors Universidad Peruana Cayetano Heredia 102
Early research (Phase 1)Study completedNCT00001830What this trial is testingDonor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow TransplantsWho this might be right forChronic Lymphocytic LeukemiaGraft vs Host DiseaseHodgkin's Disease+2 more National Cancer Institute (NCI) 110
Not applicableEnded earlyNCT03624192What this trial is testingRES Prepared With RECELL® Compared to Conventional Care for Healing of Donor Sites in Ages 1-16 YearsWho this might be right forSkin; Deformity Avita Medical 3
Not applicableUnknownNCT00964470What this trial is testingMulti-Center, Prospective, Randomized, Comparison of AWBAT™-D vs. Xeroform™ or Glucan II™ for Treatment of Donor Sites in Burn SurgeryWho this might be right forTreatment of Donor Site Burns Aubrey Inc. 60
Testing effectiveness (Phase 2)Looking for participantsNCT05588453What this trial is testingNatural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the BrainWho this might be right forClinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Malignant Neoplasm in the BrainMetastatic Melanoma+1 more Kari Kendra 24
Testing effectiveness (Phase 2)Study completedNCT00176865What this trial is testingStem Cell Transplant for Immunologic or Histiocytic DisordersWho this might be right forHemophagocytic LymphohistiocytosisX-Linked Lymphoproliferative DisordersChediak-Higashi Syndrome+3 more Masonic Cancer Center, University of Minnesota 19
Not applicableLooking for participantsNCT07685353What this trial is testingInfluence of Donor and Recipient Genetic Polymorphisms on Graft Steatosis After Liver TransplantWho this might be right forChronic Liver Disease and Cirrhosis Institute of Liver and Biliary Sciences, India 50
Not applicableEnded earlyNCT00578292What this trial is testingAllogeneic Stem Cell Transplantation, Severe Homzygous 0/+Thalassemia or Sever Variants of Beta 0/+ Thalassemia, THALLOWho this might be right forThalassemia Baylor College of Medicine 10
Not applicableActive Not RecruitingNCT04161092What this trial is testingThe Swedish Study of Liver Transplantation for Non-resectable Colorectal Cancer MetastasesWho this might be right forColorectal CancerLiver MetastasesColorectal Liver Metastases Vastra Gotaland Region 45
Not applicableStudy completedNCT02256306What this trial is testingThe PLasma for Alzheimer SymptoM Amelioration (PLASMA) StudyWho this might be right forMild-To-Moderate Alzheimer's DiseaseAlzheimer's Disease Stanford University 18
Early research (Phase 1)Study completedNCT00320606What this trial is testingWithdrawal of Immunosuppression in Pediatric Liver Transplant RecipientsWho this might be right forLiver TransplantLiver Transplantation National Institute of Allergy and Infectious Diseases (NIAID) 20
Testing effectiveness (Phase 2)Study completedNCT00105001What this trial is testingTacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic CancerWho this might be right forMyelodysplastic/Myeloproliferative Neoplasm, UnclassifiablePreviously Treated Myelodysplastic SyndromeRefractory Chronic Lymphocytic Leukemia+113 more Fred Hutchinson Cancer Center 210
Not applicableUnknownNCT06488612What this trial is testingEvaluation of the Use of Minced Skin Grafts for Promoting Donor Site Wound Healing After Split-Thickness Skin GraftingWho this might be right forTraumatic Skin Loss, 2nd and 3rd Degree Burn, Post Tumour Excision - Raw Areas Undergoes Split- Thickness Skin Grafts Sohag University 20
Not applicableLooking for participantsNCT05395767What this trial is testingLIVing Donor Allograft for Anterior Cruciate Ligament Reconstruction StudyWho this might be right forACL Maidstone & Tunbridge Wells NHS Trust 40
Testing effectiveness (Phase 2)Ended earlyNCT06271616What this trial is testingIbrutinib for the Prevention of Chronic Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell TransplantWho this might be right forChronic Graft Versus Host DiseaseHematopoietic and Lymphatic System Neoplasm Mayo Clinic 2
Large-scale testing (Phase 3)UnknownNCT06000982What this trial is testingComparison of Different Dose of Post-transplantation Cyclophosphamide as Graft Versus Host Disease ProphylaxisWho this might be right forGVHD Shanghai Jiao Tong University School of Medicine 138